BP1247
Pimobendan
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 74150-27-9
Synonym(S): 4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | BP1247-100-MG | In Stock | ₹ 25,676.90 |
BP1247 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 25,676.90
GST (18%): ₹ 4,621.842
Total Price: ₹ 30,298.742
grade
pharmaceutical primary standard
Quality Level
100
API family
pimobendan
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
CC(C(C1=CC=C(NC(C2=CC=C(OC)C=C2)=N3)C3=C1)=NN4)CC4=O
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Selleck Chemical LLC Pimobendan 5mg 74150-27-9 UD-CG 115 BS | -- | ₹ 18,156.00 | ||
eMolecules Medchem Express / Pimobendan / 5mg / 446272260 / HY-B0204 / / 74150-27-9 / [null] / 334.379 / C19H18N4O2 | -- | ₹ 9,170.56 | ||
Sigma Aldrich Fine Chemicals Biosciences Pimobendan >=98% (HPLC) | 74150-27-9 | MFCD00761648 | 50MG | -- | ₹ 50,730.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Pimobendan >=98% (HPLC) | 74150-27-9 | MFCD00761648 | 10MG | -- | ₹ 13,192.47 | ||
Sigma Aldrich Fine Chemicals Biosciences Pimobendan for system suitability European Pharmacopoeia (EP) Reference Standard | 74150-27-9 | MFCD00761648 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Pimobendan United States Pharmacopeia (USP) Reference Standard | 74150-27-9 | MFCD00761648 | 100MG | -- | ₹ 1,50,178.60 | ||
Pimobendan | -- | ₹ 1,47,880.33 | ||
Pimobendan | -- | ₹ 55,737.93 | ||
Pimobendan for system suitability | -- | ₹ 16,107.60 | ||
Pimobendan | -- | ₹ 6,230.00 - ₹ 31,150.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Pimobendan BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Pimobendan Capsules
- Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable